INSULET CORP PODD

Surgical & Medical Instruments & Apparatus · Nasdaq

기간	2026 Q2	2026 Q1	2025 FY	2025 Q3	2025 Q2	2025 Q1	2024 FY	2024 Q3
Revenues	—	—	—	—	—	—	—	—
Gross Profit	$861.30M	$409.00M	$1.16B	$1.01B	$637.70M	$306.80M	$805.60M	$798.70M
R&D Expense	$133.00M	$59.60M	$205.00M	$159.00M	$104.10M	$50.20M	$180.20M	$163.00M
SG&A Expense	$518.40M	$260.70M	$734.80M	$656.30M	$422.20M	$199.70M	$587.80M	$522.10M
Operating Income (Loss)	$209.90M	$88.80M	$220.10M	$199.60M	$111.50M	$56.90M	$37.60M	$113.60M
Interest Expense	—	—	—	—	—	—	—	—
Net Income (Loss)	$57.90M	$35.40M	$206.30M	$317.60M	$240.10M	$51.50M	$4.60M	$103.00M
EPS (Diluted)	0.82	0.50	2.94	4.40	3.32	0.73	0.07	1.47

기간	2026 Q2	2026 Q1	2025 FY	2025 Q3	2025 Q2	2025 Q1	2024 FY	2024 Q3
Total Assets	$3.19B	$3.19B	$3.09B	$3.09B	$3.09B	$3.09B	$2.59B	$2.59B
Current Assets	$1.91B	$1.91B	$1.89B	$1.89B	$1.89B	$1.89B	$1.58B	$1.58B
Cash & Equivalents	—	—	—	—	—	—	—	—
Accounts Receivable	$516.90M	$516.90M	—	—	—	—	—	—
Inventory	$452.60M	$452.60M	$430.40M	$430.40M	$430.40M	$430.40M	$402.60M	$402.60M
PP&E (Net)	—	—	—	—	—	—	—	—
Goodwill	$51.60M	$51.60M	$51.70M	$51.50M	$51.50M	$51.50M	$51.70M	$51.70M
Total Liabilities	$1.68B	$1.68B	$1.88B	$1.88B	$1.88B	$1.88B	$1.86B	$1.86B
Current Liabilities	$680.10M	$680.10M	$528.40M	$528.40M	$528.40M	$528.40M	$451.20M	$451.20M
Accounts Payable	$75.00M	$75.00M	$19.80M	$19.80M	$19.80M	$19.80M	$19.20M	$19.20M
Long-Term Debt	—	—	—	—	—	—	—	—
Stockholders Equity	$1.21B	$1.21B	$476.40M	$732.70M	$732.70M	$732.70M	$556.30M	$476.40M

기간	2026 Q2	2026 Q1	2025 FY	2025 Q3	2025 Q2	2025 Q1	2024 FY	2024 Q3
Operating Cash Flow	$260.30M	$63.80M	$145.70M	$282.70M	$174.40M	$87.60M	$119.00M	$100.50M
Investing Cash Flow	$-38.90M	$-15.60M	$-119.40M	$-78.20M	$-48.90M	$-24.00M	$-191.10M	$-87.80M
Financing Cash Flow	$-65.80M	$277.70M	$-13.60M	$-7.20M	$-5.30M	$-14.10M	$-40.30M	$-15.80M
Stock Repurchases	$30.10M	$0	$0	$0	$0	—	—	—

유사 기업

더 알아보기

데이터는 미국 SEC EDGAR 공공 데이터베이스에서 수집되었습니다. 이 사이트는 투자 조언을 제공하지 않습니다.